Dr. Scott M. Rocklage is a managing partner at 5AM Ventures. He joined this business as a venture partner in 2003, and in 2004 he was promoted to his current position. 5AM Ventures supports healthcare by financially assisting advancements in science and pharmaceuticals. 5AM ventures works with companies that put solving a patient’s needs at the forefront of the business. These companies produce unconventional ideas that become new perspectives to diagnoses and prevention plans. Read more: Scott Racklage | Crunchbase and Scott Rocklage | LinkedIn
Dr. Rocklage’s educational background began at the University of California, Berkeley, where he earned his Bachelor’s of Science in Chemistry. He received his Ph.D. in Chemistry from the Massachusetts Institute of Technology. Since expanding his education, he has made over 30 US patents and more than 100 peer-reviewed publications.
Dr. Rocklage has over three decades of experience in his field with at least 18 major affiliations including his positions as Chairman of Novira Therapeutics, Inc., Director of Rennovia Inc., and Chairman of the Board of Cidara Therapeutics, Inc.
He was also the Chairman of the Board at Cubist Pharmaceuticals in 2003, and in that year he made $1.1 million dollars. Cubicin, Teslascan and Omniscan are three drugs that received FDA approval due to Dr. Rocklage’s excellence.
In an interview with IdeaMensch, Dr. Rocklage stated that he brings ideas to life by working with entrepreneurs. He helps shape their ideas into medicines that will meet the needs of patients.
In the same session, he advises that one should never be afraid of measured risk-taking. He believes in controlling your own future through entrepreneurship.
Learn more about Scott Rocklage: